NLRP3 and liver disorder: During the development of liver diseases, downregulation of certain miRNAs (miR-223, miR-7, miR-30e, miR-22, and miR-495) or hypermethylation of miR-145 leads to increased expression of all inflammasome components and subsequent NLRP3 inflammasome activation (76–80, 87–90).